Marsico Capital Management LLC Edwards Lifesciences Corp Transaction History

Marsico Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $2.61 Million - $3.87 Million	-30,166 Reduced 39.29%	46,606 $4.43 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $2.09 Million - $2.57 Million	19,636 Added 34.37%	76,772 $9.95 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $1.52 Million - $1.9 Million	-18,123 Reduced 24.08%	57,136 $5.92 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $4.09 Million - $5.21 Million	-57,118 Reduced 43.15%	75,259 $6.87 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $6.02 Million - $7.83 Million	89,537 Added 209.0%	132,377 $10.6 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $2.47 Million - $3.3 Million	42,840 New	42,840 $2.96 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Marsico Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Marsico Capital Management LLC with notifications on news.